The WACC of Rubicon Organics Inc (ROMJ.V) is 6.9%.
Range | Selected | |
Cost of equity | 5.7% - 9.0% | 7.35% |
Tax rate | 26.2% - 27.0% | 26.6% |
Cost of debt | 4.5% - 10.3% | 7.4% |
WACC | 5.2% - 8.7% | 6.9% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 5.1% | 6.1% |
Adjusted beta | 0.37 | 0.69 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.7% | 9.0% |
Tax rate | 26.2% | 27.0% |
Debt/Equity ratio | 0.3 | 0.3 |
Cost of debt | 4.5% | 10.3% |
After-tax WACC | 5.2% | 8.7% |
Selected WACC | 6.9% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
ROMJ.V | Rubicon Organics Inc | 0.3 | -1.41 | -1.16 |
ALID | Allied Corp | 4.31 | -0.24 | -0.06 |
BAMM.CN | Body and Mind Inc | 3.99 | 0.18 | 0.05 |
EBM.V | Eastwood Bio-Medical Canada Inc | 0 | -1.44 | -1.44 |
EYEN | Eyenovia Inc | 0.33 | 1.72 | 1.38 |
FONE.CN | Flower One Holdings Inc | 52.93 | 1.84 | 0.05 |
NGW.CN | Next Green Wave Holdings Inc | 0.05 | 1.14 | 1.1 |
PCSA | Processa Pharmaceuticals Inc | 0 | 0.16 | 0.16 |
SCYX | SCYNEXIS Inc | 0.48 | 1.14 | 0.85 |
XPHY.CN | Xphyto Therapeutics Corp | 0.09 | 1 | 0.94 |
Low | High | |
Unlevered beta | 0.05 | 0.44 |
Relevered beta | 0.06 | 0.54 |
Adjusted relevered beta | 0.37 | 0.69 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for ROMJ.V:
cost_of_equity (7.35%) = risk_free_rate (4.15%) + equity_risk_premium (5.60%) * adjusted_beta (0.37) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.